home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9408c.zip
/
M9480458.TXT
< prev
next >
Wrap
Text File
|
1994-08-20
|
2KB
|
27 lines
Document 0458
DOCN M9480458
TI HTLV-II among injecting drug users in Stockholm.
DT 9410
AU Krook A; Blomberg J; Department of Immunology, Microbiology, Pathology
and Infectious; Diseases, Karolinska Institute, Huddinge University
Hospital,; Stockholm, Sweden.
SO Scand J Infect Dis. 1994;26(2):129-32. Unique Identifier : AIDSLINE
MED/94310407
AB 134 injecting drug users (IDUs) treated at the Department of Infectious
Diseases of Roslagstull Hospital, Stockholm, were tested for antibodies
to human T-lymphotropic virus, types I and II, by means of 2 HTLV-I/-II
peptide-based enzyme immunoassays (EIAs), followed by a whole-virus EIA.
Positive EIA reactions were checked and typed by electrophoretic
immunoblotting with native HTLV-I and recombinant HTLV-I and -II
proteins. 10 IDUs were diagnosed as HTLV-II seropositive. All 10 were of
Scandinavian descent. Thus, like HIV-1, HTLV-II infection has entered
the injecting drug user population in Stockholm.
DE Adult Female Human HTLV-II Antibodies/*BLOOD HTLV-II
Infections/*EPIDEMIOLOGY Immunoenzyme Techniques Male Middle Age
Prevalence Serotyping Substance Abuse, Intravenous/*COMPLICATIONS
Support, Non-U.S. Gov't Sweden/EPIDEMIOLOGY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).